GNRH1 and polycystic ovary syndrome: These results indicate that GnRH-ant pretreatment can delay follicle recruitment and development, reduce serum E2 levels before COS and make the endocrine stage before COS close to the normal physiological state in patients with PCOS at the early follicular phase.